Daniele Marinelli

Pubblicazioni

Titolo Pubblicato in Anno
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2021
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists INTERNATIONAL JOURNAL OF MEDICAL SCIENCES 2021
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors ANNALS OF ONCOLOGY 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study BIOMARKER RESEARCH 2021
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence JOURNAL OF CELLULAR PHYSIOLOGY 2020
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes JOURNAL FOR IMMUNOTHERAPY OF CANCER 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden ANNALS OF ONCOLOGY 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2020
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials CANCERS 2020
TRF2 and VEGF-A: An unknown relationship with prognostic impact on survival of colorectal cancer patients JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2020
KEAP1-NFE2L2 Mutations in NSCLC: Increased Awareness Needed. Reply to “KEAP1-NFE2L2–Mutant NSCLC and Immune Checkpoint Inhibitors: A Large Database Analysis” JOURNAL OF THORACIC ONCOLOGY 2020
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer CLINICAL AND TRANSLATIONAL MEDICINE 2020
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial CANCERS 2020
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach JOURNAL OF CLINICAL ONCOLOGY 2019
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence ANNALS OF ONCOLOGY 2017

ERC

  • LS4_12

KET

  • Big data & computing
  • Life-science technologies & biotechnologies

Keywords

Non-small cell lung cancer (NSCLC)
cancer genomics

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma